Variant report
Variant | esv3379915 |
---|---|
Chromosome Location | chr1:10911765-10915163 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568893627 | chr1:10911798-10911799 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs181016240 | chr1:10911820-10911821 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs71645070 | chr1:10911825-10911826 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs185028415 | chr1:10911867-10911868 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs570701175 | chr1:10911879-10911880 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs535013856 | chr1:10911891-10911892 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs199775770 | chr1:10911959-10911960 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs78586742 | chr1:10911960-10911961 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs70977513 | chr1:10911961-10911962 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs112765428 | chr1:10911963-10911964 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs397707604 | chr1:10911965-10911966 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
12 | rs74052550 | chr1:10911989-10911990 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs79100059 | chr1:10911990-10911991 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs535802367 | chr1:10912005-10912006 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557180126 | chr1:10912031-10912032 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
16 | rs114519075 | chr1:10912079-10912080 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
17 | rs11579472 | chr1:10912124-10912125 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545974505 | chr1:10912152-10912153 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
19 | rs34560617 | chr1:10912163-10912164 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs565714895 | chr1:10912172-10912173 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
21 | rs150646541 | chr1:10912176-10912177 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
22 | rs530372779 | chr1:10912177-10912178 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs77338557 | chr1:10912248-10912249 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
24 | rs112984948 | chr1:10912294-10912295 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550501492 | chr1:10912387-10912388 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
26 | rs375971305 | chr1:10912390-10912391 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577556261 | chr1:10912396-10912397 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
28 | rs189585153 | chr1:10912414-10912415 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
29 | rs494738 | chr1:10912430-10912431 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs551167305 | chr1:10912431-10912432 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
31 | rs139804757 | chr1:10912460-10912461 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
32 | rs201660009 | chr1:10912480-10912481 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
33 | rs373046457 | chr1:10912483-10912484 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
34 | rs637037 | chr1:10912551-10912552 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs183363544 | chr1:10912575-10912576 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
36 | rs149346360 | chr1:10912582-10912583 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
37 | rs496604 | chr1:10912624-10912625 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs116701166 | chr1:10912661-10912662 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
39 | rs539948054 | chr1:10912701-10912702 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
40 | rs558252228 | chr1:10912720-10912721 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
41 | rs146314876 | chr1:10912746-10912747 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
42 | rs535859042 | chr1:10912754-10912755 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
43 | rs555701788 | chr1:10912763-10912764 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
44 | rs573923634 | chr1:10912785-10912786 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
45 | rs544169450 | chr1:10912916-10912917 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs186075119 | chr1:10912917-10912918 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs566069399 | chr1:10912926-10912927 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs539908115 | chr1:10912938-10912939 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs1769665 | chr1:10912969-10912970 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs556993406 | chr1:10912983-10912984 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Lung cancer | 22429812 | CNVD |
Epilepsy | 22118685 | CNVD |
Schizophrenia | 22118685 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Developmental delay | 19490664 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Prader-willi syndrome | 18797701 | CNVD |
periventricular nodular heterotopia | 20648244 | CNVD |
1p36 deletion syndrome | 22283845 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Mental retardation | 20152051 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Astrocytoma | 17934521 | CNVD |
Glioblastoma | 20031968 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Glioblastoma multiforme | 16951158 | CNVD |
Neuroblastoma | 18574593 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Autism | 18414403 | CNVD |
Breast cancer | 17001317 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Wilms tumour | 19047088 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 22495311 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Neuroblastoma | 19287153 | CNVD |
Hepatocellular carcinoma | 18929564 | CNVD |
Melanoma | 17363583 | CNVD |
renal disease | 17924346 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 20808228 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:10907200-10913000 | Weak transcription | Gastric | stomach |
2 | chr1:10910600-10912000 | Weak transcription | Right Ventricle | heart |
3 | chr1:10910600-10913600 | Enhancers | Skeletal Muscle Male | skeletal muscle |
4 | chr1:10910800-10914200 | Enhancers | Skeletal Muscle Female | skeletal muscle |
5 | chr1:10911400-10912800 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
6 | chr1:10911400-10912800 | Enhancers | Psoas Muscle | Psoas |
7 | chr1:10911400-10913000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr1:10911600-10911800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr1:10911600-10913000 | Enhancers | Fetal Muscle Leg | muscle |
10 | chr1:10911800-10912800 | Enhancers | Fetal Heart | heart |
11 | chr1:10912000-10913200 | Enhancers | Right Ventricle | heart |
12 | chr1:10912800-10916200 | Weak transcription | Fetal Heart | heart |
13 | chr1:10912800-10917200 | Weak transcription | Psoas Muscle | Psoas |
14 | chr1:10913000-10913600 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
15 | chr1:10913000-10914000 | ZNF genes & repeats | Gastric | stomach |
16 | chr1:10913000-10915600 | Weak transcription | Fetal Muscle Leg | muscle |
17 | chr1:10913200-10916200 | Weak transcription | Right Ventricle | heart |
18 | chr1:10913400-10913600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
19 | chr1:10913400-10914200 | ZNF genes & repeats | Fetal Kidney | kidney |
20 | chr1:10913600-10913800 | Enhancers | Pancreas | Pancrea |
21 | chr1:10914000-10920800 | Weak transcription | Gastric | stomach |